Dentsply Sirona’s Q1 2025 Financial Performance Overview

DENTSPLY SIRONA ( (XRAY) ) has released its Q1 earnings. Here is a breakdown of the information DENTSPLY SIRONA presented to its investors.

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, providing innovative solutions to advance patient care in the dental industry. In its first quarter of 2025, Dentsply Sirona reported net sales of $879 million, a decrease of 7.7% compared to the same period in 2024, with organic sales down by 4.4%. Despite the decline in sales, the company achieved a GAAP net income of $20 million, or $0.10 per share, and an adjusted EPS of $0.43, showing resilience in a challenging market. Key financial highlights include an adjusted EBITDA margin improvement to 19.0% from 16.8% in the previous year, reflecting the company’s focus on operational efficiency and customer-centric innovation. While net sales were impacted by foreign currency fluctuations and a decrease in sales in certain segments, the company maintained its full-year outlook for organic sales and adjusted EPS, signaling confidence in its strategic initiatives. Looking ahead, Dentsply Sirona remains committed to delivering sustainable long-term performance by focusing on factors within its control, despite an uncertain macroeconomic environment.